Bottom line
FTDZX vs FBTAX: the short answer
FTDZX (Franklin Biotechnology Discovery Fund) and FBTAX (Fidelity Advisor Biotechnology Fund) are both mutual funds.
FTDZX is cheaper at 0.76% vs 0.94% — a difference of $18 a year per $10,000 invested.
Over five years, FTDZX returned +6.4% a year vs +6.4% for FBTAX (reporting dates differ).
Updated Nov 19, 2026
FTDZX vs FBTAX side by side
| FTDZX | FBTAX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Franklin Templeton | Fidelity |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.76% | 0.94% |
| Annual cost per $10k | $76 | $94 |
| 10-yr cost on $10k (prospectus) | $954 | $1,663 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +52.7% | +31.5% |
| 5-yr return (annualized) | +6.4% | +6.4% |
| 10-yr return (annualized) | +7.2% | +7.7% |
| Best quarter | — | +30.3% |
| Worst quarter | — | −27.8% |
| Net assets (fund) | $1.2B | $2.2B |
| Number of holdings | 126 | 129 |
| Portfolio turnover | 38% | 54% |
| Returns as of | Dec 31, 2025 | Sep 30, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
11 of FTDZX's top 25 holdings also appear in FBTAX's top 25.
| Holding | FTDZX | FBTAX |
|---|---|---|
| Amgen, Inc. | 4.39% | 2.37% |
| Gilead Sciences, Inc. | 3.86% | 5.70% |
| Argenx SE | 3.62% | 3.00% |
| Vertex Pharmaceuticals, Inc. | 3.54% | 1.39% |
| Revolution Medicines, Inc. | 3.01% | 3.00% |
| Ascendis Pharma A/S | 2.56% | 2.99% |
| Dianthus Therapeutics, Inc. | 2.32% | 3.55% |
| Insmed, Inc. | 1.99% | 3.05% |
| Spyre Therapeutics, Inc. | 1.87% | 3.83% |
| Oruka Therapeutics, Inc. | 1.86% | 3.24% |
| Amylyx Pharmaceuticals, Inc. | 1.32% | 2.25% |
Source: SEC Form N-PORT
FTDZX top 10
- Jazz Pharmaceuticals plc — 5.66%
- Amgen, Inc. — 4.39%
- Gilead Sciences, Inc. — 3.86%
- Regeneron Pharmaceuticals, Inc. — 3.77%
- Argenx SE — 3.62%
- Vertex Pharmaceuticals, Inc. — 3.54%
- Franklin Institutional U.S. Government Money Market Fund — 3.18%
- Revolution Medicines, Inc. — 3.01%
- Guardant Health, Inc. — 2.76%
- Ascendis Pharma A/S — 2.56%
FBTAX top 10
- Abbvie Inc — 14.71%
- Gilead Sciences Inc — 5.70%
- Spyre Therapeutics Inc — 3.83%
- Alnylam Pharmaceuticals Inc — 3.62%
- Dianthus Therapeutics Inc — 3.55%
- Cogent Biosciences Inc — 3.25%
- Oruka Therapeutics Inc — 3.24%
- Insmed Inc — 3.05%
- Revolution Medicines Inc — 3.00%
- Argenx Se — 3.00%
FAQ
What is the difference between FTDZX and FBTAX?
FTDZX (Franklin Biotechnology Discovery Fund) and FBTAX (Fidelity Advisor Biotechnology Fund) are both mutual funds. FTDZX is cheaper at 0.76% vs 0.94% — a difference of $18 a year per $10,000 invested.
Which is cheaper, FTDZX or FBTAX?
FTDZX has the lower expense ratio (0.76%).
Should I own both FTDZX and FBTAX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.